Mark Mallon

Mr. Mark Mallon is a Chief Executive Officer & Director at NeoGenomics Laboratories, Inc. and a Chief Executive Officer & Director at NeoGenomics, Inc. He is on the Board of Directors at NeoGenomics Laboratories, Inc. and NeoGenomics, Inc. Mr. Mallon was previously employed as a Chief Executive Officer & Director by Ironwood Pharmaceuticals, Inc., a President by Astrazeneca China Ltd., a Chief Operating Officer by Astrazeneca Japan Ltd., a Vice President-Marketing & Sales Operations by AstraZeneca Pharmaceuticals LP, and an Executive Vice President-International by AstraZeneca Plc. He also served on the board at Christiana Care Corp. He received his undergraduate degree from the University of Pennsylvania and an MBA from The Wharton School of the University of Pennsylvania.